
Epinote 250mg Tablet ER
Marketer
Neuracle Lifesciences Pvt Ltd
Salt Composition
Divalproex (250mg)
Overview Epinote 250mg Tablet ER
Valproex Extended-Release 250mg tablets are prescribed for epilepsy management, effectively preventing and controlling seizures. They are also indicated for migraine prophylaxis and, in some cases, bipolar disorder. This medication may be administered alone or in conjunction with other treatments; dosage and frequency are determined by your physician to optimize symptom control. The medication can be taken with or without food, but consistent daily timing maximizes therapeutic effect. Full efficacy usually takes several weeks. Continuous use as directed is crucial, even during periods of well-being, as missed doses or abrupt cessation can trigger seizures or worsen your condition. Discontinuation must be gradual and under medical supervision. Common side effects include headache, blurred vision, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia; most are mild. Continue the medication but consult your doctor if side effects persist or are bothersome. Report any skin rash or redness immediately. Prolonged use may result in osteoporosis and increased fracture risk. Suicidal ideation and behavior are rare but possible; inform your physician of any mood changes. Prior to initiating treatment, disclose any history of heart disease, kidney or liver impairment, urinary difficulties, depression, or suicidal tendencies. Inform your doctor of all medications you are currently taking to avoid potential drug interactions. Pregnant individuals should consult their doctor before starting or stopping this medication. Alcohol consumption should be avoided due to the increased risk of side effects and seizures. Regular blood tests, both pre- and post-treatment, may be necessary to monitor therapeutic drug levels.
Primary Ingredients of Epinote 250mg Tablet ER
No text provided. Please provide the text you wish to be rephrased.
Uses of Epinote 250mg Tablet ER
Managing epileptic seizures and bipolar disorder; migraine prevention.
Major Benefits of Epinote 250mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epinote 250mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Epinote 250mg Tablet ER:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Epinote 250mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Epinote 250mg Extended-Release Tablets may be consumed with or without food, though consistent timing is recommended.
How Epinote 250mg Tablet ER works:
Epinotol Extended-Release 250mg tablets are used to manage epilepsy. This anticonvulsant works by reducing heightened, erratic neuronal firing in the brain, thereby preventing seizures.
SAFETY ADVICE
AlcoholUNSAFE
Taking Epinote 250mg Extended-Release tablets with alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Epinote 250mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Epinote 250mg tablets pose minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, posing no known threat to the infant.
DrivingUNSAFE
Extended-release Epinote 250mg tablets can induce adverse reactions that might impair driving capabilities.
KidneySAFE IF PRESCRIBED
Epinote 250mg extended-release tablets can be safely administered to individuals with renal impairment. No alteration of the Epinote 250mg extended-release tablet dosage is necessary.
LiverUNSAFE
Extended-release Epinote 250mg tablets are likely unsuitable for individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Epinote 250mg Tablet ER :
Should you forget to take your Epinote 250mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Epinote 250mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Sodium channel-blocking antiepileptic drugs |
